Workflow
Nasdaq(NDAQ)
icon
Search documents
History Says the Nasdaq Will Soar in 2025. Here's the 1 AI Stock to Buy Before It Does.
The Motley Fool· 2024-12-15 10:45
The Nasdaq has blasted higher over the past two years, gaining more than 43% last year and now heading for an increase of more than 33% for 2024. This is thanks to the artificial intelligence (AI) boom, as five of the benchmark's most heavily weighted stocks and several others in the top 10 operate in this high-growth area. Today's $200 billion AI market is forecast to reach more than $1 trillion by the end of the decade, meaning companies that got involved in this technology early could greatly benefit in ...
These Are the 5 Top-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
The Motley Fool· 2024-12-15 10:07
Which stocks have driven the Nasdaq-100 higher in 2024? This eclectic collection of market leaders is dazzling investors.Investors have had much to celebrate in 2024. The tech-centric Nasdaq-100, which tracks the performance of the 100 largest nonfinancial companies in the Nasdaq Composite, has gained 28% (as of Dec. 12).Here are its best-performing stocks:Nasdaq-100 StockYear-to-Date ReturnMarket CapCompany DescriptionAppLovin (APP -0.53%)724%$113 billionApp monetizationNvidia (NVDA -2.25%)169%$3.3 trillio ...
The Nasdaq-100 Just Announced Its Latest Addition. The Stock Soared 1,090% Since Early Last Year, and It's Still a Buy Heading Into 2025, According to a Certain Wall Street Analyst.
The Motley Fool· 2024-12-14 16:18
This artificial intelligence (AI) pioneer has gained more than 1,000% in less than two years and has a vast runway ahead.The Nasdaq Composite is one of the most widely followed stock indexes in the U.S. The tech-focused index tracks the performance of more than 3,000 stocks listed on its exchange. The Nasdaq-100 is a subset of the index, tracking the performance of approximately 100 of the largest non-financial companies on the Nasdaq stock exchange. To be included in the Nasdaq-100, a company must meet the ...
History Says the Nasdaq Will Surge in 2025. 2 Stock-Split Stocks to Buy Before It Does
The Motley Fool· 2024-12-14 08:10
These tech-centric stocks have had incredible runs in 2024, but there's likely more to come.The Nasdaq Composite (^IXIC 0.12%) has been on a roll for more than two years now, with its gains fueled by improving economic conditions, the dawn of artificial intelligence (AI), an uncontested U.S. election, and recent interest rate cuts by the Federal Reserve Bank. After rising 43% in 2023, the tech-focused index has gained roughly 31% in 2024 (as of this writing).Yet students of market history will note that the ...
Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
GlobeNewswire News Room· 2024-12-13 16:53
DALLAS, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, today announced today that the Company believes it has regained compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed companies to maintain a minimum market value of listed securities of $35 ...
Nasdaq Index: Tech Stocks Retreat, but Broadcom's AI Rally Buoys Sentiment
FX Empire· 2024-12-13 16:21
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Nasdaq 100: Tech Stocks Rally as Broadcom, Nvidia Lead Semiconductor Gains
FX Empire· 2024-12-13 14:10
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Meet the Newest Stock in the Nasdaq-100. It's Soared 3,250% Since Early Last Year and Is Still a Buy Heading Into 2025, According to Wall Street.
The Motley Fool· 2024-12-13 09:10
This AI wunderkind is up more than 800% over the past year and the road ahead is long.The Nasdaq Composite is a broad-based tech-centric index that tracks the performance of more than 3,000 stocks listed on the exchange. The Nasdaq-100 is a subset of that index, tracking the performance of roughly 100 of the largest non-financial companies on the Nasdaq stock exchange, spanning a variety of sectors.To be considered for inclusion in the Nasdaq-100, a company must meet the following criteria:Be listed exclusi ...
Mountain Lake Acquisition Corp. Announces the Pricing of Upsized $210,000,000 Initial Public Offering
GlobeNewswire News Room· 2024-12-13 01:20
NEVADA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mountain Lake Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 21,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, December 13, 2024, under the ticker symbol “MLACU.” Each unit consists of one Class A ordinary share and one right. Each right entitles the holder thereof to receive one-tenth (1/10) of one Class A ordinary ...
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
GlobeNewswire News Room· 2024-12-13 01:00
BERKELEY, Calif. and MAINZ, Germany, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the pricing of a follow-on offering of 1,367,521 units, with each unit consisting of one ordinary share (or prefunded warrant in lieu thereof) one Series A warrant to purchase one ordinary share, and one series B warrant to purchase one ordinary share for gross proceeds ...